Ajanta Pharma Limited (BOM:532331)

Ajanta Pharma Statistics

Total Valuation

Ajanta Pharma has a market cap or net worth of INR 366.05 billion. The enterprise value is 362.00 billion.

Market Cap	366.05B
Enterprise Value	362.00B

Important Dates

The last earnings date was Tuesday, May 5, 2026.

Earnings Date	May 5, 2026
Ex-Dividend Date	Nov 10, 2025

Share Statistics

Current Share Class	124.89M
Shares Outstanding	n/a
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	42.24%
Owned by Institutions (%)	21.56%
Float	41.96M

Valuation Ratios

The trailing PE ratio is 34.66 and the forward PE ratio is 29.84.

PE Ratio	34.66
Forward PE	29.84
PS Ratio	6.71
PB Ratio	8.09
P/TBV Ratio	8.16
P/FCF Ratio	223.16
P/OCF Ratio	69.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.17, with an EV/FCF ratio of 220.69.

EV / Earnings	34.28
EV / Sales	6.64
EV / EBITDA	24.17
EV / EBIT	27.33
EV / FCF	220.69

Financial Position

The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.06.

Current Ratio	2.64
Quick Ratio	1.78
Debt / Equity	0.06
Debt / EBITDA	0.17
Debt / FCF	1.59
Interest Coverage	82.23

Financial Efficiency

Return on equity (ROE) is 25.39% and return on invested capital (ROIC) is 26.23%.

Return on Equity (ROE)	25.39%
Return on Assets (ROA)	14.82%
Return on Invested Capital (ROIC)	26.23%
Return on Capital Employed (ROCE)	27.95%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	5.66M
Profits Per Employee	1.10M
Employee Count	9,628
Asset Turnover	0.98
Inventory Turnover	1.29

Taxes

In the past 12 months, Ajanta Pharma has paid 3.22 billion in taxes.

Income Tax	3.22B
Effective Tax Rate	23.35%

Stock Price Statistics

The stock price has increased by +12.49% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.49%
50-Day Moving Average	2,932.73
200-Day Moving Average	2,724.13
Relative Strength Index (RSI)	41.24
Average Volume (20 Days)	10,249

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ajanta Pharma had revenue of INR 54.53 billion and earned 10.56 billion in profits. Earnings per share was 84.51.

Revenue	54.53B
Gross Profit	42.69B
Operating Income	13.25B
Pretax Income	13.78B
Net Income	10.56B
EBITDA	14.98B
EBIT	13.25B
Earnings Per Share (EPS)	84.51

Balance Sheet

The company has 6.65 billion in cash and 2.60 billion in debt, with a net cash position of 4.04 billion.

Cash & Cash Equivalents	6.65B
Total Debt	2.60B
Net Cash	4.04B
Net Cash Per Share	n/a
Equity (Book Value)	45.27B
Book Value Per Share	362.40
Working Capital	23.20B

Cash Flow

In the last 12 months, operating cash flow was 5.29 billion and capital expenditures -3.65 billion, giving a free cash flow of 1.64 billion.

Operating Cash Flow	5.29B
Capital Expenditures	-3.65B
Depreciation & Amortization	1.73B
Net Borrowing	1.98B
Free Cash Flow	1.64B
FCF Per Share	n/a

Margins

Gross margin is 78.29%, with operating and profit margins of 24.29% and 19.37%.

Gross Margin	78.29%
Operating Margin	24.29%
Pretax Margin	25.26%
Profit Margin	19.37%
EBITDA Margin	27.47%
EBIT Margin	24.29%
FCF Margin	3.01%

Dividends & Yields

This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 0.91%.

Dividend Per Share	28.00
Dividend Yield	0.91%
Dividend Growth (YoY)	-48.15%
Years of Dividend Growth	n/a
Payout Ratio	33.12%
Buyback Yield	0.18%
Shareholder Yield	1.08%
Earnings Yield	2.88%
FCF Yield	0.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 2022
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5